価格表

在庫・価格 : 2025年04月27日 22時48分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Siglec-9/Fc Chimera, Human, Recombinant, Carrier-free
データシート
1139-SL-050 RSDアールアンドディー システムズ
R&D Systems, Inc.
50 μg ¥95,000 1個 追加

在庫・価格 : 2025年04月27日 22時48分 現在

Siglec-9/Fc Chimera, Human, Recombinant, Carrier-free

  • 商品コード:1139-SL-050
  • メーカー:RSD
  • 包装:50μg
  • 価格: ¥95,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 von Gunten S et al. Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations. Blood 2006 Dec;108(13):4255-9
von Gunten S et al
2006/01/01
Species: Human, Application: bead coating, Sample type: Affigel Beads PubMed
2 Zou Z et al. Siglecs facilitate HIV-1 infection of macrophages through adhesion with viral sialic acids. PLoS ONE 2011;6(9):e24559
Zou Z et al
2011/01/01
Application: Surface Plasmon Resonance, Sample Type: HIV-1 isolates PubMed
3 Chen GY et al. Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1. Elife 2014;3:e04066
Chen GY et al
2014/01/01
Application: Bioassay, Sample Type: Cell Lysates PubMed
4 Matsubara K et al. Secreted ectodomain of sialic acid-binding Ig-like lectin-9 and monocyte chemoattractant protein-1 promote recovery after rat spinal cord injury by altering macrophage polarity. J. Neurosci. 2015 Feb;35(6):2452-64
Matsubara K et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
5 Matsumoto T et al. Soluble Siglec-9 suppresses arthritis in a collagen-induced arthritis mouse model and inhibits M1 activation of RAW264.7 macrophages. Arthritis Res. Ther. 2016 Jun;18(1):133
Matsumoto T et al
2016/01/01
Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells PubMed
6 Ito T et al. Secreted Ectodomain of SIGLEC-9 and MCP-1 Synergistically Improve Acute Liver Failure in Rats by Altering Macrophage Polarity. Sci Rep 2017 Mar;7:44043
Ito T et al
2017/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
  • No.: 1
  • 文献情報:
    von Gunten S et al. Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations. Blood 2006 Dec;108(13):4255-9
    von Gunten S et al
    2006/01/01
  • 備考:
    Species: Human, Application: bead coating, Sample type: Affigel Beads
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Zou Z et al. Siglecs facilitate HIV-1 infection of macrophages through adhesion with viral sialic acids. PLoS ONE 2011;6(9):e24559
    Zou Z et al
    2011/01/01
  • 備考:
    Application: Surface Plasmon Resonance, Sample Type: HIV-1 isolates
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Chen GY et al. Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1. Elife 2014;3:e04066
    Chen GY et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Matsubara K et al. Secreted ectodomain of sialic acid-binding Ig-like lectin-9 and monocyte chemoattractant protein-1 promote recovery after rat spinal cord injury by altering macrophage polarity. J. Neurosci. 2015 Feb;35(6):2452-64
    Matsubara K et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Matsumoto T et al. Soluble Siglec-9 suppresses arthritis in a collagen-induced arthritis mouse model and inhibits M1 activation of RAW264.7 macrophages. Arthritis Res. Ther. 2016 Jun;18(1):133
    Matsumoto T et al
    2016/01/01
  • 備考:
    Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Ito T et al. Secreted Ectodomain of SIGLEC-9 and MCP-1 Synergistically Improve Acute Liver Failure in Rats by Altering Macrophage Polarity. Sci Rep 2017 Mar;7:44043
    Ito T et al
    2017/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed